Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
en
nl
fr
de
Search
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
Working at/with Gimv
Contact
Latest news Latest news Latest news
Latest news
Filter news
Authored on
*
(Optional)
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Category
*
(Optional)
Category
Corporate
Portfolio
Investment platform
*
(Optional)
Investment platform
Consumer
Healthcare
Life Sciences
Smart Industries
Sustainable Cities
Apply
Show all
Portfolio
Leading European industrial temperature control equipment rental specialist Coolworld to be sold by Gimv to Arcus European Infrastructure Fund 3, the third fund of Arcus Infrastructure Partners
16/08/2023 - 07:28
Portfolio
Cegeka to Acquire CTG for $10.50 Per Share, Enhancing Value to Customers Across North America and Europe
09/08/2023 - 14:08
Corporate
Share buyback
01/08/2023 - 18:15
Corporate
Gimv announces share buyback in the context of a share purchase plan for its personnel
27/07/2023 - 17:45
Corporate
Outcome of the optional dividend for the FY 2022-2023: 50.8% of the dividend rights on the FY 2022-2023 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 25.2 million
26/07/2023 - 17:45
Corporate
Gimv - Modalités du dividende optionnel. Apport du droit au dividende net en échange de la souscription d'une nouvelle action à 38,22 euros ou 21 droits au dividende relatifs à l’exercice 2022/2023. Période de choix du 5 au 25 juillet 2023 inclus
29/06/2023 - 07:30
Corporate
Report of the Annual General Shareholders’ Meeting
28/06/2023 - 17:45
Portfolio
MEGA International accelerates its growth thanks to a unitranche financing from Eurazeo
07/06/2023 - 11:36
Portfolio
ERS electronic and Gimv team up to accelerate further growth and strengthening of its leadership position in the field of thermal management solutions for semiconductor manufacturing
01/06/2023 - 07:30
Corporate
Convocation for the annual general meeting of Gimv on June 28th, 2023
26/05/2023 - 17:45
Portfolio
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
24/05/2023 - 14:29
Corporate
Portfolio reaches a record level in a challenging economic environment
17/05/2023 - 06:58
Pagination
See more news
Do you want to stay updated about Gimv news?
Subscribe to our press releases
Contact information
Investor Relations Investor Relations Investor Relations
Investor Relations
Do you have any questions or require more information? Please contact us.
Contact us